Efficacy of the Wavefront Optimized (WFO) Profile in Non-anterior Astigmatisms
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study was to assess the efficacy of the Allegretto Wave excimer laser and the wavefront optimized ablation profile in correcting primarily non-anterior astigmatism faults, following laser in-situ keratomileusis (LASIK) and photorefractive keratectomy (PRK).
| Condition | Intervention |
|---|---|
|
Astigmatism |
Other: Laser in situ keratomileusis (LASIK) Other: Photorefractive keratectomy (PRK) |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Evaluation of the Efficacy of the Allegretto Wave and the Wavefront Optimized Ablation Profile in Non-anterior Astigmatisms |
- vector analysis of astigmatism correction, following laser in-situ keratomileusis (LASIK) & photorefractive keratectomy (PRK) treatments. [ Time Frame: 6 months postoperatively ] [ Designated as safety issue: No ]Vector analysis of astigmatism correction was conducted using preoperative and 6-month postoperative data. The following indexes were calculated: a) Correction index (CI) which is determined by the ratio of the surgically induced astigmatism (SIA) to the target induced astigmatism (TIA), b) Difference vector (DV) as an absolute measure of success, and, c) Index of Success (IOS) which is determined by the relationship of the DV to the TIA, as a relative measure of success.
| Enrollment: | 74 |
| Study Start Date: | April 2010 |
| Study Completion Date: | April 2011 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
LASIK group (LG group)
Volunteers of this group received LASIK treatment.
|
Other: Laser in situ keratomileusis (LASIK)
During LASIK treatments the Carriazo-Pendular microkeratome (SCHWIND eye-tech-solutions GmbH & Co.KG, Kleinostheim, Germany) with 130μm cutting head was used for the creation of the flap. The normal value of the negative pressure of the suction ring was between 600-620 mmHg and the velocity of the head movement was constant (3mm/sec). The hinge was created at the 12 o'clock position. The Allegretto Wave excimer laser (software version: 2.020 / WaveLight AG, Erlangen, Germany) was used for all ablations. Attempted ablations were modified according to the "S001 Wellington" nomogram for the "wavefront optimised" protocol.
Other Names:
|
|
PRK group (PG group)
Volunteers of this group received PRK treatment
|
Other: Photorefractive keratectomy (PRK)
The same surgical procedure was applied to all PG participants that included: Instillation of proparacaine hydrochloride 0.5% drops for topical anaesthesia, application of a sponge saturated with 10% alcohol to the central cornea for 20-30 seconds and subsequent de-epithelialization by means of a hockey knife.The Allegretto Wave excimer laser (software version: 2.020 / WaveLight AG, Erlangen, Germany) was used for all ablations. Attempted ablations were modified according to the "S001 Wellington" nomogram for the "wavefront optimised" protocol. A soft therapeutic lens was applied until complete re-epithelialization of the cornea was detected.
Other Name: Allegretto Wave excimer laser (software version: 2.020 / WaveLight AG, Erlangen, Germany)
|
Detailed Description:
Different optical components of the eye contribute to the total astigmatism error.In specific, the anterior corneal surface is responsible for the anterior component of astigmatism fault (anterior astigmatism), while the posterior corneal surface and the lens are responsible for the posterior one (posterior astigmatism).
Regarding our study, 74 refractive surgery candidates were recruited. Only one eye from each candidate was randomly enrolled in the study. Of them, 40 eyes underwent LASIK treatment (LG group), while 34 eyes underwent PRK treatment (PG group). The Allegretto Wave excimer laser (software version: 2.020 / WaveLight AG, Erlangen, Germany) was used for the ablation in all groups. Preoperatively, the ocular residual astigmatism (ORA) was calculated for each eye, according to which each astigmatism fault was characterized as primarily anterior or non-anterior.ORA is the vectorial value of astigmatism arising from non-anterior sources. Its amount on total astigmatism (R) is determined by the magnitude ratio ORA/R. Ratios below 1 indicate primarily anterior astigmatism, while ratios above 1 indicate primarily non-anterior astigmatism. 20 LG eyes and 16 PG eyes presented primarily anterior astigmatism (LG-A and PG-A subgroups, respectively), while 20 LG eyes and 18 PG eyes demonstrated primarily non-anterior astigmatism (LG-NA and PG-NA subgroups, respectively). Postoperatively, vector analysis of astigmatism correction was conducted; The following indexes were calculated: a) Correction index (CI), b) Difference vector (DV) and c) Index of Success (IOS).
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- astigmatism fault
Exclusion Criteria:
- previous incisional eye surgery
- evidence of any type of corneal pathology
- evidence of any type of optic neuropathy
- history of optic neuropathy
- diabetes mellitus
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Georgios Labiris, Senior Lecturer of Ophthalmology, Democritus University of Thrace |
| ClinicalTrials.gov Identifier: | NCT01432834 History of Changes |
| Other Study ID Numbers: | 23/29-07-11 |
| Study First Received: | September 12, 2011 |
| Last Updated: | September 12, 2011 |
| Health Authority: | Greece: Ethics Committee |
Keywords provided by Democritus University of Thrace:
|
non-anterior astigmatism correction Allegretto Wave excimer laser wavefront optimized ablation profile (WFO) LASIK PRK |
Additional relevant MeSH terms:
|
Astigmatism Refractive Errors Eye Diseases |
ClinicalTrials.gov processed this record on May 21, 2013